ACIP announces recommended 2013 adult immunization schedule
The Center for Disease Control and Prevention's Advisory Committee on Immunization Practices (ACIP) announced its recommended 2013 adult immunization schedule that includes important updates to the pneumococcal, Tdap (tetanus, ...
Health
Jan 28, 2013 |
2 / 5 (1) |
1
First-ever guidelines issued for treating type 2 diabetes in kids
(HealthDay)—For the first time ever, the American Academy of Pediatrics has issued guidelines for the management of type 2 diabetes in children and teenagers aged 10 to 18.
Diabetes
Jan 28, 2013 |
5 / 5 (1) |
0
|
At least one in five were infected in flu pandemic, international study suggests
(Medical Xpress)—At least one in five people in countries for which data are available were infected with influenza during the first year of the 2009 H1N1 pandemic, according to a new study.
Diseases, Conditions, Syndromes
Jan 25, 2013 |
not rated yet |
0
|
Discovery of new class of damage-prone DNA regions could lead to better cancer treatments
Cancer is thought to arise from DNA damage at fragile sites in the genome. A study published by Cell Press on January 24th in the journal Cell reveals a new class of fragile sites that contributes to DNA ...
Cancer
Jan 24, 2013 |
5 / 5 (1) |
0
|
Treatment targeting PI3K may delay resistance to anti-HER2 therapy in breast cancer patients
Patients with HER2-positive breast cancer being treated with anti-HER2 therapy may be able to prevent or delay resistance to the therapy with the addition of a phosphatidylinositol-3 kinase inhibitor to their treatment regimens.
Cancer
Jan 23, 2013 |
not rated yet |
0
New insights into HIV vaccine will improve drug development
Four years ago, a potential HIV vaccine showed promise against the virus that causes AIDS, but it fell short of providing the broad protection necessary to stem the spread of disease.
HIV & AIDS
Jan 10, 2013 |
not rated yet |
0
|
Small peptide ameliorates autoimmune skin blistering disease in mice
Pemphigus vulgaris is a life-threatening autoimmune skin disease that is occurs when the body's immune system generates antibodies that target proteins in the skin known as desomogleins. Desmogleins help to form the adhesive ...
Immunology
Jan 09, 2013 |
5 / 5 (1) |
0
High-dose flu vaccine better protects HIV-infected adults
(HealthDay)—HIV-infected adults achieve higher rates of seroprotection when immunized with a high-dose of the influenza trivalent vaccine compared to the standard dose, according to a study published in ...
HIV & AIDS
Jan 04, 2013 |
not rated yet |
0
Gingivitis bacteria manipulate your immune system so they can thrive in your gums
A new research report published in the Journal of Leukocyte Biology shows how the bacteria known for causing gum disease—Porphyromonas gingivalis—manipulates the body's immune system to disable normal processes that would ot ...
Diseases, Conditions, Syndromes
Jan 03, 2013 |
5 / 5 (1) |
0
|
Varizig approved to reduce chickenpox symptoms
(HealthDay)—Varizig (varicella zoster immune globulin) has been approved by the U.S. Food and Drug Administration to minimize chickenpox symptoms when administered within four days of exposure to the virus ...
Medications
Dec 22, 2012 |
not rated yet |
0
First human tests of meth medication completed
(Medical Xpress)—InterveXion Therapeutics LLC and the University of Arkansas for Medical Sciences (UAMS) have successfully completed dosing in the first human safety study of a medication to help methamphetamine users fight ...
Medications
Dec 20, 2012 |
not rated yet |
0
|
FDA approves new drug for inhaled anthrax
Federal health officials say they approved a new injectable drug from Human Genome Sciences to treat inhalable anthrax.
Medications
Dec 14, 2012 |
not rated yet |
0
Vitamin D can help infection-prone patients avoid respiratory tract infection
Treating infection-prone patients over a 12-month period with high doses of vitamin D reduces their risk of developing respiratory tract infection – and consequently their antibiotic requirement. This according to a new ...
Health
Dec 13, 2012 |
5 / 5 (1) |
0
Ebola virus uses a protein decoy to subvert the host immune response
In a study published today in the Open Access journal PLOS Pathogens, researchers at Emory University have discovered a potentially important mechanism by which the Ebola virus alters and evades the immune response of its ...
Immunology
Dec 13, 2012 |
5 / 5 (1) |
0
|
Immunogenicity strongly impacts response to adalimumab in RA
(HealthDay)—For patients with rheumatoid arthritis (RA), long-term clinical outcomes are good with etanercept and adalimumab; but for adalimumab, treatment response is strongly dependent on the presence ...
Arthritis & Rheumatism
Dec 13, 2012 |
not rated yet |
0
